Liminatus Pharma (LIMN) Shares Outstanding (2024 - 2026)
Liminatus Pharma (LIMN) posted Shares Outstanding (Entity) of $36.0 million for Q1 2026, up 33.01% sequentially from $27.1 million in Q4 2025, and up 35999489.0% YoY from N/an in Q1 2025.
Liminatus Pharma (LIMN) Shares Outstanding (2024 - 2026) Analysis & Trends
Liminatus Pharma has reported Shares Outstanding (Entity) for 3 years, with the latest figure at $36.0 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 35999489.0% year-over-year to $36.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.0 million (up 35999489.0% YoY) and the FY2025 annual result came in at $27.1 million, up 54.66% from the prior year.
- Shares Outstanding (Entity) advanced to $36.0 million in Q1 2026 per LIMN's latest filing, from $27.1 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $36.0 million in Q1 2026 and troughed at $100.0 in Q1 2025.
- A 3-year average of $21.1 million and a median of $21.8 million in 2024 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Entity) surged 48.66% in 2025, then surged 35999489.0% in 2026.
- Over 3 years, Shares Outstanding (Entity) stood at $17.5 million in 2024, then jumped by 54.66% to $27.1 million in 2025, then soared by 33.01% to $36.0 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $36.0 million, $27.1 million, and $27.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Liminatus Pharma | 256.03 Mn | 256.03 Mn | - | 48.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.00 Mn |
| Dec 31, 2025 | 23.75 Mn |
| Sep 30, 2025 | 27.01 Mn |
| Jun 30, 2025 | 23.30 Mn |
| Mar 31, 2025 | 100.00 |
| Dec 31, 2024 | 17.50 Mn |
| Sep 30, 2024 | 17.50 Mn |
| Jun 30, 2024 | 17.50 Mn |